7.68 USD
↗ 0.23 (3.09%)AT CLOSE (11:59 AM EDT)
ImmunityBio, Inc. Common Stock
IBRXNASDAQ • USD
7.69
↗ 0.01 (0.13%)
POST MARKET (AS OF 07:58 PM EDT)
Post Market
AS OF 07:58 PM EDT
7.69
↗ 0.01 (0.13%)
Market: CLOSED
IBRX is currently priced at $7.66. The stock presents a bearish profile across the board: technical indicators signal "Sell" and our fundamental models agree with a "Sell" rating. Notable factors include a concerning Altman Z-Score in the distress zone, exceptional Return on Equity (98.2%) and a bullish Golden Cross on the moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.
Technical & fundamental data as of Jul 17, 2026.
Open?$7.28
High?$7.79
Low?$7.26
Prev. Close?$7.45
Volume?9.0M
Avg. Volume?12.2M
VWAP?$7.64
Rel. Volume?0.74x
Bid / Ask
Bid?$6.69 × 100
Ask?$8.70 × 100
Spread?$2.01
Midpoint?$7.70
Valuation & Ratios
Market Cap?7.8B
Shares Out?1.0B
Float?368.2M
Float %?35.8%
P/E Ratio?N/A
P/B Ratio?-8.97
EPS?-$0.82
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
ImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases. Its approach harnesses both the adaptive and innate immune systems with the Cancer BioShield platform. The platform is built around the proprietary IL-15 superagonist ANKTIVA (nogapendekin alfa inbakicept) and is supported by a portfolio that includes adenovirus-vectored vaccines, NK-cell therapies, and additional immunomodulators. The company operates in the United States and Europe, with the majority of its revenue coming from the United States.
Themes
Employees
691
Market Cap
7.8B
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2021-03-10
Address
3530 JOHN HOPKINS COURT
SAN DIEGO, CA 92121
Phone: (844) 696-5235
SAN DIEGO, CA 92121
Phone: (844) 696-5235
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?23
Z-Score?0
Momentum?94
Short Sent.?16
Piotroski F-Score?3/9Weak
Altman Z-Score?-6.75Distress
Confidence?55%Low
Short InterestSqueeze Risk
Short % of Float?35.81%Squeeze Risk
Short Interest?131.8M
Days to Cover?8.7
Free Float368.2M
Avg Daily Volume15.2M
Settlement Date2026-06-30
Financial Health
Current Ratio?6.67Strong
Quick Ratio?6.66Strong
Cash Ratio?3.02Strong
Debt/Equity?-0.46Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?-8.97CHEAP▾
S&P97
P/S?55.35HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-32.6CHEAP▾
S&P97
EV/Sales?56.76HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?98.2%STRONG▾
Peers50
S&P97
ROA?-132.1%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-298891000
Enterprise Value?$8.0B
Fundamentals ratios updated end of day